Funding for this research was provided by:
Received: 27 December 2019
Revised: 11 February 2020
Accepted: 19 March 2020
First Online: 6 May 2020
Compliance with ethical standards
: The scientific guarantor of this publication is Professor Francesco Sardanelli (Università degli Studi di Milano).
: The authors of this manuscript declare the following relationships with companies:Thomas Helbich receives research funding from Siemens, Guerbet, Bracco, Hologic and Nocomed.Francesco Sardanelli received research grants from and is a member of the speakers’ bureau of GE Healthcare, Bayer, and Bracco; he is also a member of the Bracco Advisory Group.Fiona J Gilbert received research grants from GE Healthcare, GSK, and Hologic and had research collaborations with Volpara and Bayer. She is an NIHR senior investigator and receives funding from the Cambridge BRC.Marc Lobbes received research grant and is a member of the speakers’ bureau of GE Healthcare.Nehmat Houssami receives research funding via a National Breast Cancer Foundation (NBCF Australia) Breast Cancer Research Leadership Fellowship.
: One of the authors has significant statistical expertise.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval was obtained.
: • prospective• observational• multicenter study